Six years ago, as president and CEO of the biopharma company Chimerix, Ken Moch faced a wrenching ethical dilemma that blossomed into a full-fledged, social media-driven crisis for his company. The experience led him to grapple with big questions about leadership, including what crisis demands of a leader. (Hint: It’s more than steering through the storm.)
Ken, a skilled corporate strategist who’s taken several life sciences companies from start-up to commercialization, talks about lessons he learned leading through that crisis, and about experiences like that can catalyze necessary change.